Agree ...someone had to write such an article. Meantime, another of AZN's NSCLC medications fails P3 in same indication ...NSCLC: http://www.fiercebiotech.com/biotech/astrazeneca-notches-up-another-phiii-failure-as-lung-cancer-trial-falls-short?utm_medium=nl&utm_source=internal&mrkid=1957902&mkt_tok=eyJpIjoiTURZd1pXTmlNbU0xTlRaayIsInQiOiJLaW5kNDAyc3hMVk1zdXREb0xOQ3FSMjJKQ09QSlFGOStEbTRoQWJPNXEyMUhTNHNscFJtZEkyZFwvZENLdUxPd0xZN2xqV3ZKMkZoWmZcL3VPRHNtMWRTR2hEUFwvdmxhSUJMTlwvY0pqZlBnSXc9In0%3D